Malte Von Bonin
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis.
Journal: Bone marrow transplantation
Published: May 20, 2026
Integrated transcriptomic and TCR profiling reveals local immune dysregulation of T cells in Gl aGvHD.
Journal: Bone marrow transplantation
Published: February 06, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).
Journal: Bone marrow transplantation
Published: February 02, 2026
A convolutional neural network for fully automated total metabolic tumor volume delineation in patients with aggressive Non-Hodgkin lymphoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 11, 2025
Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.
Journal: Leukemia
Published: October 16, 2025
Measurable residual disease by multicolor flow cytometry in acute myeloid leukemia: A comparison of peripheral blood and bone marrow.
Journal: Cytometry. Part B, Clinical cytometry
Published: September 18, 2025
Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMML.
Journal: HemaSphere
Published: September 05, 2025
Venetoclax plus high-dose cytarabine and mitoxantrone as salvage treatment for relapsed or refractory acute myeloid leukaemia (RELAX): a multicentre, single-arm, phase 1/2 trial.
Journal: The Lancet. Haematology
Published: September 01, 2025
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.
Journal: Bone marrow transplantation
Published: July 27, 2025
Last Updated: 09/26/2026